Introduction
Klinefelter syndrome (KS) was described for the first time in 1942 by Klinefelter, with a report of nine men with gynecomastia, small testes, germinal epithelium and Sertoli cell impairment. The classic form of KS (~80-90% of the cases) is due to the presence of an extra X chromosome (karyotype 47,XXY). In the remaining 10-20% of the cases, there are higher-grade aneuploidies (48,XXXY, 49,XXXXY or 48, XXYY), or mosaicisms (mainly 46,XY/47,XXY) (Bonomi et al., 2017; Tartaglia et al., 2011; Mazzilli et al., 2016) .
The numerical chromosome aberrations can arise from a maternal (in about half of all cases) or paternal non-disjunction. Maternal XXY can be caused by an error during meiosis I (MI) (the most frequent) or meiosis II. On the contrary, XXY of paternal origin can arise only by a MI error (Lanfranco et al., 2004) . Additionally, a precocious separation of sister chromatids may cause trisomies in human oocytes (Angell, 1991; Handyside et al., 2012; Capalbo et al., 2017; Segawa et al., 2017) . The origin of the XXY karyotype can arise also through an error at an early mitotic division in the developing zygote (Lanfranco et al., 2004) .
The prevalence of KS is 1-2/1000 in male newborns, 3-4/100 in adult infertile males and 10-12/100 among azoospermic subjects (Maclean et al., 1964; Hamerton et al., 1975; Nielsen and Wohlert, 1990; Forti et al., 2010) . The prevalence of KS in prenatal examinations with amniocentesis or chorion villi sampling has been reported for a total of 76 526 males, resulting in 163 foetuses with a 47,XXY karyotype (~0.2%) (Bojesen et al., 2003) . In 70% of the cases, the foetuses were legally aborted, while in the remaining 30% of the cases, there was no spontaneous abortion or stillbirth, suggesting an absence of increased risk to the pregnancy due to KS. To our knowledge, no data are available regarding the prevalence of XXY karyotype among the embryos analysed with preimplantation genetic testing for aneuploidies (PGT-A) during IVF cycles.
The KS phenotype is extremely variable and depends on the supernumerary X chromosome and the effects of hypogonadism. Common traits are tall stature, eunuchoid skeleton, small testes, azoospermia or infertility, gynecomastia and metabolic disorders (Greco et al., 2001; Ferlin et al., 2010; Radicioni et al., 2010; Selice et al., 2010 Selice et al., , 2013 Nieschlag et al., 2016; Bonomi et al., 2017; Calogero et al.et al., 2017) .
A recent meta-analysis conducted by Corona et al. highlighted a successful surgical sperm retrieval rate, by performing testicular sperm extraction (TESE) or micro-TESE, in 50% of the cases. The pregnancy and live birth rates then after IVF were~50% (Corona et al., 2017) .
Notably, there are men with a XXY karyotype and less evident signs, namely less severe forms of KS, which often may go undetected. Furthermore, the majority of men with of KS are diagnosed after referral for infertility. Therefore, the real prevalence of KS could be underestimated, as supposed by Bonomi et al. (2017) .
No risk factor for 47,XXY karyotype in products of conception has been yet clearly defined to date. Advanced maternal age, and possibly paternal age, have been suggested (Bojesen et al., 2003) . Nonetheless, especially for the latter, a definite cut-off to classify a man of 'advanced paternal age' is also missing. Some authors have proposed 35 years (Meijerink et al., 2016), others 40 (de La Rochebrochard and Thonneau, 2003) . Finally, an increased prevalence of aneuploidies involving specifically sex chromosomes in blastocysts derived from couples with severe oligozoospermia has been reported (Coates et al., 2015) , suggesting a role for the sperm factor as putative risk factor of KS.
No data are available regarding the prevalence of XXY karyotypes among the blastocysts analysed during PGT-A cycles. The purpose of this study was to evaluate the prevalence of KS among 7549 blastocysts biopsied during PGT-A cycles conducted at six different IVF clinics in Italy. We also aimed to investigate the correlation between putative confounders and the prevalence of 47,XXY karyotype.
Materials and Methods
This is a cohort study that involved 7549 trophectoderm biopsies performed between April 2013 and September 2017, during 2826 PGT-A cycles at six different IVF clinics in Italy (G.EN.E.R.A. centres in Rome, Naples, Umbertide and Marostica, Humanitas centre in Rozzano and Demetra centre in Florence), and analysed by quantitative-PCR (qPCR) at a single genetic centre (Igenomix, Italy).
PGT-A was performed in cases of: (i) advanced maternal age (AMA, defined as maternal age over 35 years) (86.6% of cycles); (ii) recurrent pregnancy loss (RPL, defined as at least three previous miscarriages) (0.7%); and (iii) the couple's own decision (12.7%).
Only couples undergoing PGT-A and whose male and female partner showed a normal karyotype, 46,XY and 46,XX, respectively, were included. Exclusion criteria were sperm or oocyte donation cycles and cycles involving PGT for monogenic disease (PGT-M) or chromosomal structural abnormalities (PGT-SR). Subjects with sperm count <5 million/ ml included in the study had a normal Y chromosome microdeletion analysis. Only the first cycle for each included couple was considered. The Institutional Review Board of the Clinics approved the study.
Semen analysis was performed according to WHO guidelines (WHO 2010). All the procedures have been thoroughly described previously (Mazzilli et al., 2017) . Briefly, semen samples were collected by masturbation after 3-5 days of sexual abstinence and analysed by optical microscope. Sperm concentration, total sperm number, progressive motility and morphology were evaluated. In cases of obstructive azoospermia (OA), spermatozoa were recovered through testicular fine-needle aspiration (FNA) or surgically through TESE in cases of non-obstructive azoospermia (NOA) or ineffective FNA (Van Peperstraten et al., 2008) .
Ovarian stimulation was performed with recombinant FSH (rec-FSH) and GnRH antagonist treatment, as previously described (Ubaldi et al., 2010 . After 35-36 h of induction of final oocyte maturation, oocyte retrieval was carried out through transvaginal ultrasound-guided aspiration. ICSI, blastocyst culture, trophectoderm biopsy and vitrification were performed as previously described (Rienzi et al., 1998; Cobo et al., 2012; Capalbo et al., 2014) . All expanded blastocysts were biopsied independently of their morphological quality. Morphological quality was defined as follows (as previously defined in (Capalbo et al., 2014) based on a method adapted from Gardner and Schoolcraft, 1999) : excellent (≥3AA), good (3,4,5,6, AB and BA) average (3,4,5,6 BB, AC and CA) and poor (≤3BB), based on the inner cell mass (A = numerous tightly packed cells; B = several and loosely packed cells; C = very few cells) and trophectoderm (A = many cells organized in epithelium; B = several cells organized in loose epithelium; C = few large cells) quality scores.
The genetic analysis of trophectoderm cells was performed by a certified cytogeneticist. Comprehensive chromosomal testing was carried out by qPCR, with a multiplex amplification of 96 loci and a method of relative quantification, as previously described Capalbo et al., 2015) . A karyotype prediction of the copy number status of each chromosome for each embryo was made. Only uniform whole chromosome aneuploidies could be detected by qPCR.
All of the putative confounders were included in the logistic regression analyses: maternal and paternal age, sperm factor, previous conception(s), cause of infertility (idiopathic, male factor, endocrine-ovulatory, endometriosis, tubal or other), main indication for PGT, duration of infertility, number of previous failed IVF cycles, number of previous miscarriages and blastocyst quality. Finally, sub-analyses of the main results according to maternal and paternal ages and to sperm factor and blastocyst quality were conducted.
Statistical analysis
Continuous data are presented as mean with SD and range. Categorical variables are presented as absolute and percentage. Chi square was used to assess differences between categorical variables clustered per classes of patients (e.g. ranges of female age). Continuous variables among different groups were compared through the ANOVA test. A post-hoc power calculation was performed for the incidence of 47,XXY karyotype among male blastocysts without autosomal aneuploidies per ranges of maternal age at oocyte retrieval and per blastocyst morphological quality. The software G*power was used to this end.
Logistic regressions were performed to evaluate putative associations with a 47,XXY karyotype, as well as 45,X or 47,XXX karyotypes. The models included all the variables listed above. Univariate analyses were performed and finally multivariate analyses were performed for putative predictors. A P-value threshold of 0.05 was used to define statistical evidence of an interaction. The software R was used for statistics.
Results
A total of 7549 blastocysts were analysed from 2826 PGT-A cycles. Overall, 3474 blastocysts were euploid (1777 blastocysts were euploid male, 1697 were euploid female), 4011 were aneuploid for autosomal chromosomes (53.2%) and 64 were aneuploid for sex chromosomes (0.8%) (Fig. 1) . Among them, 40 were 45,X (0.5%), 7 were 47,XXX (0.1%) and 17 were 47,XXY (0.2%). There were also 45 blastocysts carrying other XXY karyotypes associated with autosomal aneuploidies ( Supplementary Fig. S1 ). Globally then, 62 XXY karyotypes were produced from this cohort of patients (associated or not with autosomal aneuploidies).
The prevalence of a 47,XXY karyotype among male blastocysts without autosomal aneuploidies was 0.9% (n = 17/1794) (Fig. 1B) . None of the couples produced more than one embryo with an XXY karyotype.
The results were analysed also per ranges of maternal age (≤35, 36-38 and ≥39 years), paternal age (<40, 41-50 and ≥51 years), per semen parameters (namely, normozoospermia (N), moderate male factor (MMF) (with sperm concentration ≥5 and <15 ×10 6 /ml), cryptozoospermia or severe oligoasthenoteratozoospermia (OAT-S) (with sperm concentration <5 ×10 6 /ml), OA and NOA), and per blastocyst quality (excellent, good, average and poor).
Maternal age
The mean maternal age was 38.8±3.4 years (range 23.1-44.0). The prevalence of 47,XXY karyotypes among male blastocysts without autosomal aneuploidies was 0.2% (n = 1/566), 0.8% (n = 5/654) and 1.9% (n = 11/574) if considering subgroups per female range age ≤35, 36-38 and ≥39 years, respectively (P < 0.01) ( Fig. 2A) . A post-hoc power calculation was performed to evaluate the strength of these data, which resulted in 95% of statistical power.
Paternal age
The mean paternal age was 42.3±5.5 years (range: 31.1-57.0). The results were plotted according to male age range (<40, 41-50 and ≥51 years). The prevalence of 47,XXY karyotypes was similar in the three groups (0.9%, n = 5/577, 1.0%, n = 11/1107 and 0.9%, n = 1/ 110, respectively; P=NS) ( Supplementary Fig. S2A ).
Sperm factor
There was no statistically significant difference regarding the prevalence of 47,XXY karyotypes among the different sperm quality groups when considering only male blastocysts (0.9%, n = 8/847, 1.2%, n = 5/410 and 0.8%, n = 4/474, in N, MMF and OAT-S, respectively; P=NS). No 47,XXY karyotype was observed in the OA and NOA groups ( Supplementary Fig. S2B ).
Blastocyst quality
The prevalence of 47,XXY karyotypes among male blastocysts without autosomal aneuploidies was 0.5% (n = 6/1177), 1.3% (n = 3/ 235), 2.2% (n = 4/178) and 2.0% (n = 4/204) if considering subgroups per blastocyst quality range: excellent, good, average and poor, respectively (P = 0.04) (Fig. 2B) . A post-hoc power calculation was performed to evaluate the strength of these data, which resulted in 95% of statistical power.
Logistic regression (47,XXY karyotypes)
Univariate and multivariate logistic regression analyses were performed to investigate the association of possible confounding factors (maternal and paternal age at oocyte retrieval, sperm factor, previous conception, cause of infertility, main indication for PGT-A, duration of infertility, number of previous failed IVF cycles, number of previous miscarriages, blastocyst morphology) with the possibility of a blastocyst showing a 47,XXY karyotype among male blastocysts without autosomal aneuploidies. Univariate analyses showed a correlation between maternal age and blastocyst quality and the occurrence of a 47,XXY karyotype among euploid blastocysts without autosomal aneuploidies, as already outlined with the Chi-square tests reported above. Multivariate analysis confirmed these results (OR: 1.20, 95% CI: 1.01-1.42; P = 0.04, and OR: 1.6, 95% CI: 1.13-2.45; P = 0.01, respectively).
No association was found between a 47,XXY karyotype and the other variables under investigation.
Comparison between 47,XXY karyotypes and other sex chromosome aneuploidies
The prevalence of blastocysts carrying only sex chromosome aneuploidies (namely 47,XXY, 45,X and 47,XXX) among all the blastocysts biopsied was 0.8% (n = 64/7549) (Fig. 1) , while among blastocysts with normal numbers of autosomes, it was 1.8% (n = 64/3538).
The most frequent sex aneuploidy observed was a 45,X (Fig. 1) . Overall, the prevalence of this karyotype among all the tested blastocysts was 0.5% (n = 40/7549); among blastocysts with normal numbers of autosomes, it was 1.1% (n = 40/3514) and among female blastocysts with normal numbers of autosomes, it was 2.3% (n = 40/ 1737).
Furthermore, the prevalence of 47,XXX karyotypes among all the tested blastocysts was 0.1% (n = 7/7549); among all blastocysts with normal numbers of autosomes, it was 0.2% (n = 7/3481) and among female blastocysts with normal numbers of autosomes, it was 0.4% (n = 7/1704) (Fig. 1) .
Other sex chromosome aneuploidies (i.e. XYY, XXXY, XXXYY) were observed only in association with autosomal aneuploidies.
In 2016, Katz-Jaffe et al., reported that the mean maternal and paternal age in couples producing at least one blastocyst carrying only sex chromosome aneuploidies was lower when compared to couples producing autosomal aneuploid blastocysts (Katz-Jaffe et al., 2017). The mean age of women producing blastocysts with a 47,XXY, 45,X, 47, XXX karyotype and blastocysts with autosomal aneuploidies was 38.9 ±2.6 (31-42), 37.2±3.8 (30-44), 38.4±4.6 (32-43) and 39.0±3.1 (23-44) (P = 0.01) in our study. Hence, the occurrence of a missegregation causing a 45,X blastocyst was more common in younger women than was an imbalance causing either a trisomy involving the sex chromosomes or any autosomal aneuploidy. The mean age of men producing blastocysts with a 47,XXY, 45,X, 47,XXX karyotype and blastocysts with autosomal aneuploidies was 42.3±7.1 (32-55), 40.2±5.1 (31-46), 43.7±4.8 (36-50) and 42.3±5.5 (31-57) (P=NS).
In this case, although the men producing 45,X blastocysts were younger on average, no significant difference was highlighted.
Logistic regression (trisomic karyotypes for sex chromosomes or 45,X karyotypes)
Univariate and multivariate logistic regression analyses were performed to investigate the association of possible confounders with the possibility of a blastocyst showing a trisomic karyotype for sex chromosomes (47,XXY and 47,XXX) or a 45,X karyotype among all the blastocysts without autosomal aneuploidies. Again, only maternal age and the blastocyst morphology correlated with the occurrence of sex chromosome trisomies (OR: 1.18, 95% CI: 1.06-1.32, P < 0.01 and OR: 1.58, 95% CI: 1.23-2.04, P < 0.01). Conversely, no variable under investigation correlated with the occurrence of a 45,X karyotype.
Discussion
In this study, the prevalence of a 47,XXY karyotype among male blastocysts without autosomal aneuploidies produced during PGT-A cycles was 0.9%. To our knowledge, these are the first data available on this topic at this stage of development. Four different putative scenarios may arise from these data: (i) the prevalence of KS in male newborns reported in literature (0.1-0.2%) (Maclean et al., 1964; Hamerton et al., 1975; Nielsen and Wohlert, 1990; Forti et al., 2010) may indeed be underestimated, as theorized by Bonomi et al.; (ii) 47, XXY blastocysts result in a lower implantation rate than euploid embryos (previously estimated as ≈50%) Forman et al., 2013; Capalbo et al., 2014; Dahdouh, Balayla, and GarciaVelasco, 2015) ; (iii) 47,XXY blastocysts result in a higher miscarriage rate than euploid embryos (previously estimated as ≈10%) (Chen et al., 2015) ; or (iv) the prevalence of 47,XXY karyotypes may be higher in the blastocysts derived from a population of infertile patients undergoing IVF and of advanced maternal age.
Regarding the first hypothesis, this study provides novel data putatively corroborating the theory by Bonomi et al. Indeed, the phenotype of men affected by KS is extremely variable and less severe forms of the syndrome with less evident signs exist, therefore some affected individuals may go undiagnosed (Bonomi et al., 2017) . However, before the embryo results in a birth, it must first implant and overcome the risk of a miscarriage. While we cannot demonstrate a lower implantation for 47,XXY blastocysts (second hypothesis), unless some couples would choose to transfer them, some hints about the miscarriage rate may instead derive from prenatal diagnosis (PND)-related data. Specifically, Bojesen et al. reported a 0.2% prevalence of 47,XXY karyotype (163 foetuses out of a total of 76526) among prenatal examinations (amniocentesis or chorion villus) of males foetuses. Of these, 70% (114) were legally aborted, while the remaining 30% resulted in a newborn (Bojesen et al., 2003) . Thus, no miscarriage was shown. Similarly, Marteau et al. (2002) did not report any miscarriage among 111 women with a PND of 47,XXY who did not undergo legal abortion, in their dataset. Finally, Gruncy et al. (2011) also showed a diagnosis of 47,XXY in the prenatal period equal to 0.17% (n = 188/ 106 000 pregnancies), out of which only two (1.1%) miscarried. Only Jo et al. (2013) reported a miscarriage rate slightly higher (n = 2/22, 9.1%), although the prevalence of KS in foetuses in this study was as low as 0.12% (n = 22/18049 males). Obviously, we should consider that from all these studies some of the foetuses were legally aborted, thereby limiting the definition of the real miscarriage rate of the overall population of implanted 47,XXY embryos. To our knowledge, there is only one recently published retrospective study conducted after single blastocyst transfer in IVF. Here, the authors analysed 1030 products of conceptions (POC) and defined an overall 0.2% prevalence of the 47, XXY karyotype among males (Segawa et al., 2017) . In contrast with the KS-related karyotype, the prevalence of 45,X (Turner syndrome) has been instead reported to range 0.2-0.4% in PND (specifically 0.4% with chorion villus analysis and 0.2% with amniocentesis) (Gravholt et al., 1996; Segawa et al., 2017) , 3-4% in POC (~6% considering only female), and only 0.04% among female newborns (Nielsen and Wohlert, 1991) . In our study, the prevalence of a 45,X karyotype among female blastocysts without autosomal aneuploidies was 2.3% (0.5% overall). If we compare this prevalence to the rates reported for POC and PND, we can reasonably suppose that 45,X blastocysts result in a lower implantation rate and a higher miscarriage rate, as previously suggested (Hook and Warburton, 1983) . However this reproductive fate is possibly not shared by the blastocysts carrying a KS-related karyotype. Indeed, in general, the prevalence of KS in PND from all the studies previously cited (0.2% on average) matches with the one commonly reported for the population of male newborns. Unfortunately, in this study we did not have information regarding the karyotypes of POCs in early miscarriages after PGT-A. In fact, we follow the pregnancies up to the 22nd gestational week and all the information about the live births are generally obtained by interviewing the patients post-delivery. Therefore, we cannot yet exclude the risk of a higher miscarriage rate for 47,XXY foetuses (third hypothesis) and future investigations of this issue are certainly required.
The main limitation of all these hypotheses is that the populations among which the different prevalence are calculated are very heterogeneous: couples with advanced maternal age population and undergoing PGT-A in this study, selected populations of foetuses in cases of PND, spontaneous miscarriages in case of POC analyses, and the general population who have a karyotype analysis in case of newborns. Yet, these are the only data produced to date to investigate and cautiously speculate upon this important topic. Therefore, we proposed and examined also a fourth hypothesis, namely that infertile couples undergoing IVF may show a higher predisposition to generate 47,XXY embryos. The logistic regression analyses here performed outlined a significant association with maternal age and blastocyst quality (OR: 1.2 and 1.6, respectively). Conversely, paternal age and sperm factor, which were previously proposed as variables possibly correlated with an increased prevalence of sex aneuploidies in general (Franasiak et al., 2014; Garcia-Ferreyra et al., 2015; Coates et al., 2015) , here did not show any association with 47,XXY karyotypes.
When focusing only on the population of patients obtaining aneuploid embryos, the mean age of women producing a 47,XXY (or 47, XXX) blastocyst was significantly lower with respect to patients producing blastocysts aneuploid for autosomal chromosomes, but higher than patients producing 45,X ones. On average, also the men producing a 45,X blastocyst were generally younger, but not significantly younger. Besides partially supporting the data reported by Katz-Jaffe et al. (2017) , this evidence suggests that even if maternal meiotic impairments (and their increasing impact as the woman ages) are the main mechanism resulting in aneuploidies in general, possibly they share an important impact with paternal meiotic and mitotic errors when it comes to sex chromosome aneuploidies. In this regard, unfortunately, qPCR has been technically and clinically validated as a highly reliable technique only to detect full-chromosome uniform aneuploidies from a trophectoderm biopsy Capalbo et al., 2015; Goodrich et al., 2016) , but it cannot resolve maternal meiotic errors from paternal ones, it shows no (or too low) sensibility to mosaicism and it may leave sub-chromosomal impairments undetected. Therefore, some putative mosaic blastocysts presenting a karyotype compatible with KS (as well as those with triple-X or especially Turner syndrome) might have gone undiagnosed from this cohort of embryos.
If we focus only on the range of female age <35 years, namely, the least populated class according to woman age in this study, the prevalence of 47,XXY karyotype among male blastocysts without autosomal aneuploidies was 0.2%, which is in line with the prevalence reported in male newborns from previous epidemiological studies (0.1-0.2%). Nonetheless, the population of women conceiving and delivering in the general population is possibly more represented by women younger than 35, and to our knowledge, no data per subclasses of female age have been published to report the prevalence of KS across ranges of maternal age. Therefore, the speculations comparing the prevalence of KS at the blastocyst stage with the prevalence of KS after birth are limited from the different features of the cohorts of couples from which they were calculated. Indeed, the possibility that the former may be over-estimated and the latter underestimated are equally valid options at present and require investigations from less heterogenous cohorts in the future.
Finally, our results showed a correlation between maternal age (also if corrected per blastocyst morphology) and the occurrence of a 47, XXY karyotype, suggesting a prevalent meiotic impairment of oogenesis in its aetiology. Conversely, no association of 45,X karyotypes was shown with maternal age. Therefore, we can hypothesize that this imbalance instead follows a different pattern of missegregation. Specifically, it may be caused more frequently by a meiotic error during spermatogenesis and/or a mitotic error post-fertilization. Unfortunately however, the proportion of paternally and maternally derived cases, as well as the putative mitotic origin of this error cannot be assessed through the method used in this study (i.e. qPCR on a single trophectoderm biopsy). Therefore, a thorough search of the literature focused on the postnatal analyses of KS, triple-X and Turner syndrome was performed, which highlighted the following schemes: (i) KS can be equally caused by a missegregation in either spermatogenesis or oogenesis, mostly in meiosis I (and less frequently in mitosis post-fertilization, <10% of cases), but its prevalence does not show a correlation with increased paternal age as it does with maternal age (Carothers et al., 1984; Jacobs et al., 1988; MacDonald et al., 1994; Shi et al., 2002) ; (ii) triple-X is caused by an error in maternal meiosis iñ 90% of cases and is indeed largely dependent upon maternal age May et al., 1990; MacDonald et al., 1994) ; and (iii) Turner syndrome is mainly caused by an error in paternal meiosis (60-80% of cases), but again is not correlated with paternal age Jacobs et al., 1990; Mathur et al., 1991; Uematsu et al., 2002) . Generally, a reduced recombination between the sex chromosomes was suggested as the leading cause of these imbalances, which may in part justify their independence from paternal aging (Shi et al., 2002; Thomas and Hassold, 2003) . Indeed, spermatogenesis does not undergo a long quiescent period as oogenesis does, and possibly the area of recombination among the 'X' and the 'Y' chromosomes, which are limited to the pseudo-autosomal sequences, may involve a more error-prone mechanism in general.
To conclude, in the light of the above observations and related hypotheses, we confirmed the data produced in this study on human blastocysts. Both 47,XXY and 47,XXX karyotypes show an increased incidence in older women (but not in older men), while the 45,X karyotype is independent from parental age and therefore may show a constant incidence throughout the maternal/paternal reproductive lifespan. In our opinion, these data are valuable as a background to counsel those couples who may have to face this issue during IVF treatments.
Conclusion
The prevalence of a 47,XXY karyotype in male blastocysts produced during PGT-A cycles is~1%. If compared to the 0.1-0.2% which has been reported in both male newborns and foetuses by PND, we may hypothesize that: (i) the prevalence in male newborns may be underestimated; (ii) 47,XXY blastocysts show a lower implantation; and/or (iii) a higher early miscarriage rate than euploid blastocysts; or (iv) the prevalence of 47,XXY karyotypes from a population of infertile couples of mainly advanced maternal age women as candidates for PGT-A is higher than in the general population.
In this regard, especially since advanced maternal age showed a significant correlation with 47,XXY karyotypes among male blastocysts without autosomal aneuploidies, infertile women undergoing an IVF cycle should be informed about this possibility, and properly counselled about the reproductive fate of these embryos and the clinical manifestations of this syndrome in the newborns. These novel data shed some light and encourage careful considerations upon a still unclear issue of human reproduction.
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